Treatment of hyperlipidaemia with fenofibrate and related fibrates

Author： Filippatos Theodosios   Milionis Haralampos J  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.10, 2008-10, pp. : 1599-1614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ezetimibe complements fenofibrate in mixed hyperlipidaemia

By  

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Efficacy, Safety and Tolerability of Combined Low-Dose Simvastatin-Fenofibrate Treatment in Primary Mixed Hyperlipidaemia

By C. Stefanutti  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 465-477

Adis International

Access to resources Recommend Favorite

Fibrates and Statins in the Treatment of Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 396-405

Bentham Science Publishers

Access to resources Recommend Favorite

Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia

By Penzak Scott R   Chuck Susan K  

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 5-17

Informa Healthcare

Access to resources Recommend Favorite

Effects of Fluvastatin Treatment on Insulin Sensitivity in Patients with Hyperlipidaemia

By Cingözbay BY   Top C   Terekeci H   Keskin O¨   önde ME  

The Journal of International Medical Research, Vol. 30, Iss. 1, 2002-01 ,pp. : 21-25

Field House Publishing

Access to resources Recommend Favorite